(Q37777759)

23 August 2017

1 reference

title

Targeting apoptosis pathways in cancer by Chinese medicine (English)

1 reference

23 August 2017

0 references

1 reference

ChEBI release 2020-05-28

Min Li-Weber

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

3 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0304383510003630?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

https://api.elsevier.com/content/article/PII:S0304383510003630?httpAccept=text/plain

16 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

16 June 2024

1 reference

23 August 2017

volume

332

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

304-312

1 reference

Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors

23 August 2017

cites work

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M109.090209

Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.2174/187152006777698123

Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction

1

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Life and death in peripheral T cells

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

The TRAIL apoptotic pathway in cancer onset, progression and therapy

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Regulation of cell death: the calcium-apoptosis link

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

The apoptosome: signalling platform of cell death

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Bid: a Bax-like BH3 protein.

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Mitochondria as therapeutic targets for cancer chemotherapy

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Smac mimetics and TNFalpha: a dangerous liaison?

16 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

16 June 2024

The Hallmarks of Cancer

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Promoting apoptosis as a strategy for cancer drug discovery

16 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Apoptosis pathways and their therapeutic exploitation in pancreatic cancer

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

TRAIL/TRAIL-R in hematologic malignancies

16 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Mitochondrial formation of reactive oxygen species

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Production of large amounts of hydrogen peroxide by human tumor cells

16 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Reactive oxygen species in cancer cells: live by the sword, die by the sword.

16 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Anti-cancer properties of anthraquinones from rhubarb

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines.

16 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells

16 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Artemisinin: mechanisms of action, resistance and toxicity

16 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Progress towards the discovery of xanthine oxidase inhibitors.

16 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation

16 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin

16 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

The importance of glutathione in human disease

16 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Flavonoid-induced glutathione depletion: potential implications for cancer treatment

16 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

16 June 2024

GammaH2AX and cancer

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Artesunate derived from traditional Chinese medicine induces DNA damage and repair.

16 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.

16 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3.

16 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Berberine: Complex with DNA

16 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD

16 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis

16 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Direct activation of the mitochondrial calcium uniporter by natural plant flavonoids

16 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Current insights into the regulation of programmed cell death by NF-kappaB.

16 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications

16 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity

16 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

16 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway

16 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Celastrol: Molecular targets of Thunder God Vine

16 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation

16 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo

16 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion

16 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

NF-kappaB activation by reactive oxygen species: fifteen years later

16 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance

16 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Structure-antioxidant activity relationships of flavonoids and phenolic acids

16 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis

16 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Impacts of baicalein analogs with modification of the 6th position of A ring on the activity toward NF-kappaB-, AP-1-, or CREB-mediated transcription

16 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells.

16 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases

16 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Translational control in cancer.

16 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Targeting the RAF-MEK-ERK pathway in cancer therapy

16 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure

16 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

RNA polymerase - an important molecular target of triptolide in cancer cells

16 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Phosphorylation and functions of the RNA polymerase II CTD

16 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities

16 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression

16 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression

16 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway

16 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.

16 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Concepts of activated T cell death

16 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system

16 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells

16 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

CD95 promotes tumour growth

16 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.07.015

16 June 2024

Identifiers

1 reference

23 August 2017

1 reference